Trade Summary

5 days ago, Ra Capital Management, L.P., serving as 10% owner at Werewolf Therapeutics, Inc. (HOWL), sold 565,167 shares at $0.69 per share, for a total transaction value of $390,688.00. Following this transaction, Ra Capital Management, L.P. now holds 406,282 shares of HOWL.

This sale represents a 58.00% decrease in Ra Capital Management, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 8, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 12, 2026, 4 days after the trade was made.

Werewolf Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.